Was gibt es Neues bei der Klassifikation der peripheren T-Zell-Lymphomen?-Reference-Cited by-同舟云学术

Was gibt es Neues bei der Klassifikation der peripheren T-Zell-Lymphomen?

Published:2023-12 Issue:S3 Volume:44 Page:128-135
ISSN:2731-7188
Container-title:Die Pathologie
language:en
Short-container-title:Pathologie

Author:

de Leval Laurence^ORCID,Bisig Bettina^ORCID

Abstract

AbstractIn this review focus article, we highlight the main modifications introduced in the latest 2022 International Consensus Classification and World Health Organization classification (ICC and WHO-HAEM5) of mature T (and NK) cell neoplasms (PTCLs) and consequent implications for diagnostic practice. The changes result from recent advances in the genomic and molecular characterization of PTCLs and enhanced understanding of their pathobiology. Specifically, consideration is given to the following groups of diseases: Epstein–Barr virus (EBV)-associated neoplasms; follicular helper T cell lymphoma; anaplastic large cell lymphomas; primary intestinal T and NK cell lymphomas and lymphoproliferative disorders; and PTCL, not otherwise specified.

Funder

University of Lausanne

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00292-023-01260-y.pdf

Reference28 articles.

1. Alaggio R, Amador C, Anagnostopoulos I et al (2022) The 5th edition of the world health organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia 36:1720–1748

2. Amador C, Bouska A, Wright G et al (2022) Gene expression signatures for the accurate diagnosis of peripheral T‑cell Lymphoma entities in the routine clinical practice. J Clin Oncol 40:4261–4275

3. Amador C, Greiner TC, Heavican TB et al (2019) Reproducing the molecular subclassification of peripheral T‑cell lymphoma-NOS by immunohistochemistry. Blood 134:2159–2170

4. Bachy E, Camus V, Thieblemont C et al (2022) Romidepsin plus CHOP versus CHOP in patients with previously untreated peripheral T‑cell Lymphoma: results of the Ro-CHOP phase III study (conducted by LYSA). J Clin Oncol 40:242–251

5. Campo E, Jaffe ES, Cook JR et al (2022) The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee. Blood 140:1229–1253